We evaluate and generate evidence for in vitro diagnostics and help accelerate their development and adoption. Part of @NIHRresearch and hosted by @ImperialNHS.
š Our Centre has officially launched! We offer research and navigation services for innovators at all stages of IVD development.
Our initial focus is on cancer, infectious and respiratory diseases, critical care, primary and social care.
Find out more: hrc-invitro.nihr.ac.uk
It was a pleasure to attend the @IVDHRC launch event last Friday. Great day of networking and talks from researchers, PPIE representatives, regulatory and industrial bodies. Looking forward to keep working together!
@profgeorgehanna@ImperialSandC@ImperialMed@imperialcollege
We have reached our limit for tickets for Biomarker Accelerator 2025. We are going to add a waiting list and are looking for a bigger venue. Thanks for your enthusiasm! @ImperialSandC@IVDHRCeventbrite.co.uk/e/biomarkerā¦
š We rounded off today with a panel of regulatory and industry bodies to discuss how they are addressing the NHS 10 Year Plan.
Thank you to everyone who joined the Official Launch of the HealthTech Research Centre today!
hrc-invitro.nihr.ac.uk/
āWhat you can do for me might not be that effective, but what I can do for you really worksā
Our PPIEP Board Member, Stella, on the importance of involving patients and the public in research, from the start.
š§ We prioritise five themes to tackle unmet needs in areas highlighted in the NHS Long Term Plan.
- Methodology
- Cancer
- Respiratory and Infectious Diseases
- Primary and Social Care
- Critical Care
hrc-invitro.nihr.ac.uk/themeā¦
š The Centre has officially launched! Our āone-stopā world-class research facility to generate evidence needed to accelerate adoption of IVDs in the NHS - is open.
hrc-invitro.nihr.ac.uk/
At the HRC's Official Launch, hear Lightning Talks from Nadine Neale @MHRAgovuk, Helen Dent @BIVDA and Steve Lee @UK_ABHI, and they will discuss the NHS 10 Year Plan and the three strategic shifts on a panel.
Final tickets here: launch-of-HRC-IVD.eventbriteā¦
IMPACT: Our team completed Human Factors studies on Viso, an @OmronHealthEU remote patient monitoring service, to provide insights into its potential to change clinical hypertension management in primary care.
Find out more: london.ivd.nihr.ac.uk/case-sā¦
Is your IVD focused on addressing needs in cancer, infectious and respiratory diseases, critical care, or primary and social care?
Our team supports innovators to generate evidence, develop their tests, and navigate the market.
Find out more: london.ivd.nihr.ac.uk/
Weāre excited to announce our latest investment into the future of science and tech š”
Weāve invested in a site in Old Oak, West London, which will become a home for cutting-edge innovation and turbocharge the newly formed WestTech Corridor š£ļø
imperial.ac.uk/news/257114/iā¦
MedTech SMEs can apply for £30,000 funding for use with regulatory affairs providers to help them navigate regulatory pathways.
Deadline: 31 October 2024 at midday
digitalhealth.net/2024/10/4-ā¦@ukCPI@UK_Life_Science
Innovators who want to understand market entry, fundraising, and partnerships with China: HiMed Angel Fund is hosting one-day bootcamps in London (29 Oct) and Harlow (30 Oct).
Book your free tickets:
@LBICLondonshorturl.at/u8Ipb@AriseInnovationshorturl.at/V8eLF
The NIHR MIC scheme has come to an end. This channel now represents the work of the new NIHR HealthTech Research Centre in In Vitro Diagnostics.
Find out more about the HRCs here: nihr.ac.uk/support-and-serviā¦